Literature DB >> 7380333

Plasma clearance of oral and intravenous cholic acid in subjects with and without chronic liver disease.

I T Gilmore, R P Thompson.   

Abstract

The apparent plasms clearances of tracer amounts of radiolabelled cholic acid given orally or intravenously were compared in 14 control subjects and 20 patients with chronic liver disease. The clearance after oral administration was the more sensitive in detecting chronic liver disease and correlated better with the fasting levels of endogenous serum bile acid. This agrees with the predicted effects on clearance of hepatocellular damage and portal-systemic shunting of blood after the two routes of administration. The estimated hepatic extraction ratio, calculated from the ratio of the oral and intravenous clearances, was 0.77+/-0.02 (mean+/-SEM) in control subjects, 0.64+/-0.03 in patients with anicteric chronic liver disease, and 0.46+/-0.05 in those with icteric chronic liver disease.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7380333      PMCID: PMC1419343          DOI: 10.1136/gut.21.2.123

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  15 in total

1.  Hepatic bile acid transport: effect of conjugation and position of hydroxyl groups.

Authors:  N E Hoffman; J H Iser; R A Smallwood
Journal:  Am J Physiol       Date:  1975-08

2.  Diagnositic value of serum bile acid estimations in liver disease.

Authors:  S Barnes; G A Gallo; D B Trash; J S Morris
Journal:  J Clin Pathol       Date:  1975-06       Impact factor: 3.411

3.  Plasma disappearance of radioactivity after intravenous injection of labeled bile acids in man.

Authors:  A E Cowen; M G Korman; A F Hofmann; P J Thomas
Journal:  Gastroenterology       Date:  1975-06       Impact factor: 22.682

4.  Sensitivity of serum bile acid assay for detection of liver damage in viral hepatitis type B. Prospective study in five patients.

Authors:  A F Hofmann; M G Korman; S Krugman
Journal:  Am J Dig Dis       Date:  1974-10

5.  Studies on the haemodilution anaemia of splenomegaly.

Authors:  L M Blendis; C Ramboer; R Williams
Journal:  Eur J Clin Invest       Date:  1970-03       Impact factor: 4.686

6.  Hepatocellular uptake of bile acids in the dog: Evidence for a common carrier-mediated transport system. An indicator dilution study.

Authors:  J C Glasinović; M Dumont; M Duval; S Erlinger
Journal:  Gastroenterology       Date:  1975-10       Impact factor: 22.682

7.  The binding of cholic acid and its taurine conjugate to serum proteins.

Authors:  C W Burke; B Lewis; D Panveliwalla; S Tabaqchali
Journal:  Clin Chim Acta       Date:  1971-04       Impact factor: 3.786

8.  Acute taurine depletion and maximal rates of hepatic conjugation and secretion of cholic acid in the dog.

Authors:  E R O'Máille; T G Richards; A H Short
Journal:  J Physiol       Date:  1965-09       Impact factor: 5.182

9.  The influence of conjugation of cholic acid on its uptake and secretion: hepatic extraction of taurocholate and cholate in the dog.

Authors:  E R O'Máille; T G Richards; A H Short
Journal:  J Physiol       Date:  1967-04       Impact factor: 5.182

10.  Serum bile acids in liver disease.

Authors:  G Neale; B Lewis; V Weaver; D Panveliwalla
Journal:  Gut       Date:  1971-02       Impact factor: 23.059

View more
  10 in total

Review 1.  Molecular changes in hepatic metabolism and transport in cirrhosis and their functional importance.

Authors:  Christoph G Dietrich; Oliver Götze; Andreas Geier
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

Review 2.  Ursodeoxycholic acid in the treatment of cholesterol cholelithiasis. Part II.

Authors:  W H Bachrach; A F Hofmann
Journal:  Dig Dis Sci       Date:  1982-09       Impact factor: 3.199

3.  Clinical value of bile salt tests in anicteric liver disease.

Authors:  J G Douglas; G J Beckett; I A Nimmo; N D Finlayson; I W Percy-Robb
Journal:  Gut       Date:  1981-02       Impact factor: 23.059

Review 4.  Noninvasive assessment of liver function.

Authors:  Steve Helmke; Jordi Colmenero; Gregory T Everson
Journal:  Curr Opin Gastroenterol       Date:  2015-05       Impact factor: 3.287

5.  Endogenous bile acid tolerance test for liver function.

Authors:  M van Blankenstein; M Frenkel; J W van den Berg; F J ten Kate; E P Bosman-Jacobs; A C Touw-Blommesteyn
Journal:  Dig Dis Sci       Date:  1983-02       Impact factor: 3.199

6.  Serum bile acids and oral ursodeoxycholic acid tolerance test in the diagnosis of esophageal varices.

Authors:  M Kadohara; H Kawasaki; C Hirayama
Journal:  Gastroenterol Jpn       Date:  1987-10

7.  Description and simulation of a physiological pharmacokinetic model for the metabolism and enterohepatic circulation of bile acids in man. Cholic acid in healthy man.

Authors:  A F Hofmann; G Molino; M Milanese; G Belforte
Journal:  J Clin Invest       Date:  1983-04       Impact factor: 14.808

8.  Pharmacokinetics of naftopidil, a novel anti-hypertensive drug, in patients with hepatic dysfunction.

Authors:  M J Farthing; E M Alstead; S M Abrams; G Haug; A Johnston; R Hermann; G Niebch; P Ruus; K H Molz; P Turner
Journal:  Postgrad Med J       Date:  1994-05       Impact factor: 2.401

9.  Role of bile acids in the diagnosis and progression of liver cirrhosis: A prospective observational study.

Authors:  Ning Liu; Jiao Feng; Yang Lv; Qing Liu; Jingfan Deng; Yujing Xia; Chuanyong Guo; Yingqun Zhou
Journal:  Exp Ther Med       Date:  2019-09-17       Impact factor: 2.447

10.  Total bile acid-to-cholesterol ratio as a novel noninvasive marker for significant liver fibrosis and cirrhosis in patients with non-cholestatic chronic hepatitis B virus infection.

Authors:  Li-Ting Yan; Li-Li Wang; Jia Yao; Ya-Ting Yang; Xiao-Rong Mao; Wei Yue; Yong-Wu Mao; Wei Zhou; Qing-Feng Chen; Yu Chen; Zhong-Ping Duan; Jun-Feng Li
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.